Allon Therapeutics Inc. reports Q1 loss of $1.2M after switch to biotech

VANCOUVER (CP) - Allon Therapeutics Inc. said Friday its first-quarter loss widened to $1.2 million from $54,347 as it continued its transformation from a biotechnology investment company into a drug developer....More